Somatix Therapy Corp regulatory update

SOMA said U.S. Patent No. 5,460,959 issued to Massachusetts Institute of Technology's Whitehead Institute for Biomedical Research, covering genetically modified fibroblasts. The Alameda, Calif., compa...